Poseida Therapeutics Inc (NAS:PSTX)
$ 3.265 0.345 (11.82%) Market Cap: 316.47 Mil Enterprise Value: 164.00 Mil PE Ratio: 0 PB Ratio: 3.02 GF Score: 35/100

Poseida Therapeutics Inc at Bank of America Healthcare Conference Transcript

May 10, 2022 / 09:40PM GMT
Release Date Price: $2.16 (+2.37%)
Alec Stranahan
Bank of America Merrill Lynch - Analyst

Good afternoon, everyone. Welcome to the end of day 1 or nearing the end of day 1 of the 2022 Bank of America Healthcare Conference. Thanks for joining this session with Poseida Therapeutics. My name is Alec Stranahan; I'm Vice President and senior biotech analyst covering Poseida at BofA. And I'm pleased to be joined today by Mark Gergen, Chief Executive Officer of Poseida.

Mark, welcome.

Mark Gergen
Poseida Therapeutics, Inc. - CEO

Hey, thanks. Thanks for having us. Happy to be here.

Alec Stranahan
Bank of America Merrill Lynch - Analyst

Yeah. Yeah. So I believe Mark is going to run through just some intro comments, and then we can jump right into the Q&A.

So over to you, Mark.

Mark Gergen
Poseida Therapeutics, Inc. - CEO

Very good. Well, again, thanks for having us today. Happy to be here. Nice to get back out in the live world again. So good to be doing that. Just a word from my lawyer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot